The Rise of "Smart-Pipelines": Predictive Analytics and Data Harmonization in Antibody Research
The complexity of manufacturing biological drugs has led to a massive shift in how the industry operates. In 2026, many pharmaceutical companies are no longer building their own factories; instead, they are relying on Contract Development and Manufacturing Organizations (CDMOs). These specialized partners provide the infrastructure and expertise required to scale production from a few...
0 التعليقات 0 المشاركات 10 مشاهدة 0 معاينة